By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acacia Pharma 

Harston Mill

Harston  Cambridge  CB22 7GG  United Kingdom
Phone: +44-(0)1223-875130 Fax: +44-(0)1223-875131




Company News
Acacia Pharma Announces Positive Results From A Pivotal Phase 3 Trial Of BAREMSIS For The Treatment Of Post-Operative Nausea & Vomiting 8/12/2016 6:43:01 AM
Acacia Pharma Added To Large-Cap Russell 1000 Market Index 6/27/2016 10:00:23 AM
Acacia Pharma Initiates Second Pivotal Phase 3 Treatment Study With Baremsis (APD421) In Post-Operative Nausea & Vomiting (PONV) 3/21/2016 6:00:25 AM
Three All-Or-Nothing Biotech Companies 2/22/2016 6:45:25 AM
Acacia Pharma Announces Positive Results From Second Pivotal Phase 3 Study Of BAREMSIS (APD421) In Prevention Of Post-Operative Nausea & Vomiting 1/5/2016 6:32:57 AM
Acacia Pharma: Dr Patrick Vink To Succeed Ian Kent As Non-Executive Chairman 12/3/2015 6:56:15 AM
Acacia Pharma Announces Positive Results From Phase 2 Study With APD403 In Chemotherapy Induced Nausea & Vomiting (CINV) 5/6/2015 6:21:15 AM
Acacia Pharma Touts Positive Phase 3 Data For APD421 10/7/2014 6:10:26 AM
Acacia Pharma Announces Positive Phase 2 Results With APD515 for Xerostomia in Advanced Cancer 10/15/2013 8:03:51 AM
Acacia Pharma Initiates Pivotal Phase 3 Studies With APD421 in Post-Operative Nausea & Vomiting (PONV) 9/17/2013 9:07:52 AM